Redeye updates its estimates after Sleep Cycle’s Q3 2023 report, which was in line with our sales es...
Redeye makes minimal estimate adjustments following the Q3’23 report, in which the reported figures ...
Q3 net sales and clean EBIT were above Refinitiv consensus expectations.
ESL Shipping volumes may have been weak in Q3. SSAB has already said that demand was weak in Q3 and ...
Quarterly order intake of SEK 160-180m likely maintainable '23e-'25e adj.
Back to growth across geographies Strong momentum for Boråstapeter brand We raise the fair value ran...
Q3e: sales SEK 511m, up 17% y-o-y, adj. EBITA margin 6.
Vitrolife is going through a period with softer organic growth in the 3-6% which compares with a mor...
Redeye comments on Invisio’s Q3-results which saw stronger topline than expected while EBITDA was so...
Solid Service revenue growth of 30%
Redeye updates its estimates after Ependion’s Q3 2023 report, which came in close to our forecasts, ...
Redeye comments on SenzaGen’s Q3 2023 sales update.
Redeye concludes that the figures in the Q3’23 report were mainly in line with our projections.
Finnair’s Q3 EBIT was impressive even if higher fuel prices already had some adverse impact.
Etteplan reports Q3 results on October 31st. We anticipate a slower quarter due to the prevailing ma...
Sales +5% y-o-y, -6% vs. ABGSCe on lower delivery sales 11% adj.
Redeye leaves an initial comment following the Q3 report published by Magle this morning.
Net sales SEK 183m, 10% vs ABGSCe, 13% vs Factset cons.
Next milestone, preparation for mesdopetam's EOP2 meeting Activities to secure funding for after H1'...
Redeye comments on Sleep Cycle's Q3 2023 report, which was in line with our sales estimates but stro...
